4.7 Review

Pharmacological management of cancer pain: Novel therapeutics

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 156, 期 -, 页码 -

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113871

关键词

Cancer pain; Pharmacology; Opioids; Sarcoma; NSAID; Acetaminophen; Antidepressant

资金

  1. National Heart, Lung, and Blood Institute (NHBLI) [5K01HL144882-3]
  2. Center for Redox Biology and Cardiovascular Disease Grant [3P20GM121307-03S1]

向作者/读者索取更多资源

Patients diagnosed with cancer often experience pain during treatment, and concerns about adverse effects and addiction may result in under-dosing of opioids. Therefore, there is a need for novel non-opioid pain treatments for cancer patients.
Patients diagnosed with cancer often experience pain during their treatment course, making it difficult to care for themselves and continue with their activities of daily living. When cancer is found at later stages, the pain can become severe and constant; reducing their quality of life and significantly affecting mental and physical well-being. Despite opioids being known to provide adequate analgesia for higher pain levels, they are often the reason for under-dosing because of their adverse effects and concern for addiction. There are also patients who do not respond well to opioids because of genetic anomalies or personal preference. Therefore, there is a need for novel non-opioid cancer pain treatments. There are many new cancer pain treatments that are emerging. This manuscript discusses cancer pain, risk factors, epidemiology, guidelines for the treatment of cancer pain, personalization of cancer pain therapy, breakthrough pain, cancer-induced peripheral neuropathy, established cancer pain treatment options, and novel emerging cancer pain treatment options.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据